Cryptococcus neoformans galactoxylomannan is a potent negative immunomodulator, inspiring new approaches in

Anna Vecchiarelli1, Eva Pericolini, Elena Gabrielli

  • 1Microbiology Section, Department of Experimental Medicine & Biochemical Sciences, University of Perugia, Via del Giochetto, 06126 Perugia, Italy. vecchiar@unipg.it

Immunotherapy
|August 17, 2011
PubMed

Insights

Galactoxylomannan (GalXM), a component of Cryptococcus neoformans, induces apoptosis in immune cells, contributing to fungal virulence. This immune suppression offers potential therapeutic applications for autoimmune diseases.

Area of Science:

  • Mycology
  • Immunology
  • Pathogen Biology

Background:

  • Cryptococcus neoformans is an opportunistic fungal pathogen causing severe infections.
  • Its virulence is linked to capsular polysaccharides, primarily glucuronoxylomannan (GXM) and galactoxylomannan (GalXM).
  • GalXM, despite its lower concentration, has unique biological properties and is shed in tissues.

Purpose of the Study:

  • To review the immunomodulatory effects of GalXM over the past two decades.
  • To elucidate the mechanisms by which GalXM induces apoptosis in immune cells.
  • To explore the therapeutic potential of GalXM's immunosuppressive properties.

Main Methods:

  • Literature review of studies on GalXM's immunomodulatory effects.
  • Analysis of mechanisms of apoptosis induction in lymphocytes and macrophages.
  • Evaluation of GalXM's role in C. neoformans virulence.

Main Results:

  • GalXM induces apoptosis in T lymphocytes, B lymphocytes, and macrophages.
  • This induction of apoptosis contributes to immune suppression and C. neoformans virulence.
  • GalXM's smaller molecular mass may lead to higher molar concentrations when shed.

Conclusions:

  • GalXM possesses significant immunomodulatory capabilities, primarily through inducing apoptosis.
  • The immunosuppressive effects of GalXM are a key factor in C. neoformans pathogenesis.
  • GalXM's properties may be harnessed for treating autoimmune disorders characterized by immune cell overactivation.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...